Literature DB >> 30861528

Thyroid Nodules Are More Prevalent in Subjects with Colon Polyps, Independent of Insulin Resistance.

Umut Mousa1, Cuneyd Anil2, Canan Cicek Demir3, Yusuf Bozkus3, Kubra Ozturk4, Neslihan Bascil Tutuncu3, Alptekin Gursoy2.   

Abstract

OBJECTIVE: Colorectal polyps and thyroid nodules are common disorders linked to hyperinsulinemia and metabolic syndrome (Mets). The direct association between these two diseases is not clear. We aimed to analyze the prevalence of thyroid nodules in subjects with and without colorectal polyps. The secondary aim was to establish the prevalence of Mets and its parameters in both disorders and to determine if insulin resistance and hyperinsulinemia are common underlying pathophysiological mechanisms. SUBJECTS AND METHODS: One hundred and five subjects with colorectal polyps (71 males, 34 females) and 68 controls (28 males, 40 females) were enrolled. The parameters of Mets together with TSH, insulin, low-density lipoprotein cholesterol, and homeostasis model for assessment of insulin resistance levels were calculated. We performed thyroid ultrasonography in all participants.
RESULTS: The prevalence of Mets was similar in the colorectal polyp and control groups (37.1 vs. 37.3%, p = 0.982). The prevalence of Mets was nonsignificantly higher in subjects with a documented thyroid nodule compared to subjects without a thyroid nodule (43.0 vs. 32.6%, p = 0.205). The prevalence of thyroid nodules in subjects with colorectal polyps was significantly higher than in subjects without polyps (52.9 vs. 35.3%, p = 0.017). Compared to subjects with no colorectal polyps, we established a significant increase in the odds of having thyroid nodules (OR 2.05; 95% CI: 1.097-3.860, p = 0.017). The presence of colorectal polyps and age in the adjusted model were established to be independent risk factors for having thyroid nodules (p = 0.025 and p = 0.007, respectively).
CONCLUSION: These results may support the presence of other common mechanisms in the development of these two pathologies other than insulin resistance and hyperinsulinemia. ©2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Nodule; Polyps; Thyroid volume

Mesh:

Year:  2019        PMID: 30861528      PMCID: PMC6771071          DOI: 10.1159/000499527

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  23 in total

1.  Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)

Authors:  B Balkau; M A Charles
Journal:  Diabet Med       Date:  1999-05       Impact factor: 4.359

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study.

Authors:  Takako Morita; Shinji Tabata; Masamichi Mineshita; Tetsuya Mizoue; Malcolm A Moore; Suminori Kono
Journal:  Asian Pac J Cancer Prev       Date:  2005 Oct-Dec

Review 4.  Diets link metabolic syndrome and colorectal cancer development (Review).

Authors:  Jirakrit Saetang; Surasak Sangkhathat
Journal:  Oncol Rep       Date:  2017-01-18       Impact factor: 3.906

5.  [Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl)].

Authors:  J Brunn; U Block; G Ruf; I Bos; W P Kunze; P C Scriba
Journal:  Dtsch Med Wochenschr       Date:  1981-10-09       Impact factor: 0.628

6.  Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue.

Authors:  F Minuto; A Barreca; P Del Monte; G Cariola; G C Torre; G Giordano
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

7.  Obesity is associated with an increased prevalence of advanced adenomatous colon polyps in a male veteran population.

Authors:  Ali Siddiqui; Helene N Pena Sahdala; Hector E Nazario; Amar Mahgoub; Mahir Patel; Daisha Cipher; Stuart Spechler
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

8.  Is metabolic syndrome a risk factor for colorectal adenoma?

Authors:  Jeong Hwan Kim; Yun Jeong Lim; Young-Ho Kim; In-Kyung Sung; Sang Goon Shim; Sung-Ook Oh; Sin-Sil Park; Sun Yang; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee; Yoon-Ho Choi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

Review 9.  The link between the metabolic syndrome and cancer.

Authors:  Sandra Braun; Keren Bitton-Worms; Derek LeRoith
Journal:  Int J Biol Sci       Date:  2011-08-16       Impact factor: 6.580

10.  Association between Nutrient Intake and Metabolic Syndrome in Patients with Colorectal Cancer.

Authors:  Hee-Sook Lim; Eung-Jin Shin; Jeong-Won Yeom; Yoon-Hyung Park; Soon-Kyung Kim
Journal:  Clin Nutr Res       Date:  2017-01-31
View more
  1 in total

1.  Presence of Metabolic Syndrome and Thyroid Nodules in Subjects with Colorectal Polyps.

Authors:  Yue Yu; Jiansheng Wu
Journal:  Med Sci Monit       Date:  2021-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.